Source: Apollo Life Sciences
Date: November 17, 2006
Summary:
In a world first, Apollo Life Sciences has revealed that two of its human proteins, which are wholly derived from human cells, are up to 53% faster in generating vital white blood cells used in the treatment of chemotherapy patients. This means cancer patients who normally have to wait for up to three weeks for white blood cell levels to regenerate before embarking on subsequent courses of chemotherapy can access potentially life saving treatments earlier. In the future, it is anticipated that patients will benefit from quicker recovery times from chemotherapy, as well as avoiding a host of side effects involved in their treatment.
No comments:
Post a Comment